Are WHO and UNAIDS supporting the programmatic roll-out of recency testing by partners such as PEPFAR?

Current (2015) WHO HIV Testing Service guidelines do not include recency testing as part of HIV diagnosis or for use within index client testing and partner notification services. WHO is in discussions with global partners about evidence required to inform WHO technical guidelines processes and potential submission for PQ assessment. At this time, WHO has endorsed the use of recency assays for epidemiologic and surveillance purposes (e.g., without return of results) but has not recommended use of such assays at individual patient management. This may change pending additional evidence.